ZEB2 and ZEB1 expression in a spontaneous canine model of invasive micropapillary carcinoma of the mammary gland

Research in Veterinary Science

Volumn 97, Issue 3, 2014, Pages 554-559

  Gamba, C O ^a   Campos, L C ^a   Negreiros Lima, G L ^a   Maciel Lima, K ^a   Sousa, L P ^a   Estrela Lima, A ^b   Ferreira, E ^a   Cassali, G D ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Canine; Immunohistochemistry; Invasive micropapillary carcinoma; Mammary gland; ZEB1; ZEB2

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ZEB1; TRANSCRIPTION FACTOR ZEB2; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; REPRESSOR PROTEIN;

ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BREAST CARCINOMA; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DOG; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HISTOPATHOLOGY; IMMUNOREACTIVITY; INVASIVE MICROPAPILLARY CARCINOMA OF THE MAMMARY GLAND; METASTASIS; MITOSIS INDEX; NONHUMAN; OVERALL SURVIVAL; PROTEIN ANALYSIS; PROTEIN DENATURATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL RATE; TUMOR VOLUME; WESTERN BLOTTING; ANIMAL; CELL NUCLEUS; CELL SURVIVAL; CYTOPLASM; EXPERIMENTAL MAMMARY NEOPLASM; IMMUNOHISTOCHEMISTRY; METABOLISM; PAPILLARY CARCINOMA; PHYSIOLOGY;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, PAPILLARY; CELL NUCLEUS; CELL SURVIVAL; CYTOPLASM; DOGS; FEMALE; HOMEODOMAIN PROTEINS; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, ANIMAL; REPRESSOR PROTEINS;

EID: 84919384276     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2014.09.016     Document Type: Article

References (31)

1. Aigner K., Dampier B., Descovich L., Mikula M., Sultan A., Schreiber M., et al. The transcription factor ZEB1 (dEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 2007, 26:6979-6988.
2. Cassali G.D., Gobbi H., Malm C., Schmitt F.C. Evaluation of accuracy of fine needle aspiration cytology for diagnosis of canine mammary tumours: comparative features with human tumours. Cytopathology 2007, 18:191-196.
3. Cassali G.D., Lavalle G.E., De Nardi A.B., Ferreira E., Bertagnolli A.C., Estrela-Lima A., et al. Consensus for the diagnosis, prognosis and treatment of canine mammary tumors. Brazilian Journal of Veterinary Pathology 2011, 4:153-180.
4. Cassali G.D., Lavalle G.E., Ferreira E., Estrela-Lima A., De Nardi A.B., Fernandes C.G., et al. Consensus for the diagnosis, prognosis and treatment of canine mammary tumors - 2013. Brazilian Journal of Veterinary Pathology 2014, 7:38-68.
5. De Sousa L.P., Brasil B.S., Silva B.M., Freitas M.H., Nogueira S.V., Ferreira P.C., et al. Plasminogen/plasmin regulates c-fos and egr-1 expression via the MEK/ERK pathway. Biochemical and Biophysical Research Communications 2005, 329:237-245.
6. Elston C.W., Ellis I.O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991, 19:403-410.
7. Elston C.W., Ellis I.O. Assessment of histological grade. The Breast 1998, 365-384. Churchill Livingstone, London, UK. C.W. Elston, I.O. Ellis (Eds.).
8. Gamba C.O., Dias E.J., Ribeiro L.G., Campos L.C., Estrela-Lima A., Ferreira E., et al. Histopathological and immunohistochemical assessment of invasive micropapillary mammary carcinoma in dogs: a retrospective study. The Veterinary Journal 2013, 196:241-246.
9. Geradts J., De Herreros A.G., Su Z., Burchette J., Broadwater G., Bachelder R.E. Nuclear Snail1 and nuclear ZEB1 protein expression in invasive and intraductal human breast carcinomas. Human Pathology 2011, 42:1125-1131.
10. Graham T.R., Zhau H.E., Odero-Marah V.A., Osunkoya A.O., Kimbro K.S., Tighiouart M., et al. Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Research 2008, 68:2479-2488.
11. Kahlert C., Lahes S., Radhakrishnan P., Dutta S., Mogler C., Herpel E., et al. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro. Clinical Cancer Research 2011, 17:7654-7663.
12. Karihtala P., Auvinen P., Kauppila S., Haapasaari K.M., Jukkola-Vuorinen A., Soini Y. Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype. Breast Cancer Research and Treatment 2013, 138:81-90.
13. Lemma S., Karihtala P., Haapasaari K.M., Antunen E., Soini Y., Bloigu R., et al. Biological roles and prognostic values of the EMT-mediating transcription factors Twist, ZEB1 and Slug in diffuse large B-cell lymphoma. Histopathology 2013, 62:326-333.
14. Maeda G., Chiba T., Okazaki M., Satoh T., Taya Y., Aoba T., et al. Expression of SIP1 in oral squamous cell carcinomas; implication for E-cadherin expression and tumor progression. International Journal of Oncology 2005, 27:1535-1541.
15. Marinho V.F.Z., Sanches F.S.F., Rezende M.A., Andrade V.P., Gobbi H. Carcinoma micropapilar invasor da mama: aspectos anatomopatológicos, imuno-histoquímicos e evolutivos de um tipo histológico subdiagnosticado. Jornal Brasileiro de Patologia e Medicina Laboratorial 2007, 43:57.
16. Histological Classification of Mammary Tumors of the Dog and the Cat 1999, World Health Organization, Geneva, Switzerland, 58 pp. W. Misdorp, R.W. Else, E. Hellmen (Eds.).
17. Miura N., Yano T., Shoji F., Kawano D., Takenaka T., Ito K., et al. Clinicopathological significance of Sip1-associated epithelial mesenchymal transition in non-small cell lung cancer progression. Anticancer Research 2009, 29:4099-4106.
18. Montserrat N., Gallardo A., Escuin D., Catasus L., Prat J., Gutiérrez-Avignó F.J., et al. Repression of E-cadherin by SNAIL, ZEB1, and TWIST in invasive ductal carcinomas of the breast: a cooperative effort?. Human Pathology 2011, 42:103-110.
19. Nam E.H., Lee Y., Zhao X.F., Park Y.K., Lee J.W., Kim S. ZEB2-Sp1 cooperation induces invasion by upregulating cadherin-11 and integrin α5 expression. Carcinogenesis 2014, 35:302-314.
20. TNM Classification of tumors in Domestic Animals 1980, 26-32. World Health Organization, Geneva, Switzerland. L.N. Owen (Ed.).
21. Oztas E., Avci M.E., Ozcan A., Sayan A.E., Tulchinsky E., Yagci T. Novel monoclonal antibodies detect Smad-interacting protein 1 (SIP1) in the cytoplasm of human cells from multiple tumor tissue arrays. Experimental and Molecular Pathology 2010, 89:182-189.
22. Rakha E.A., El-Sayed M.E., Lee A.H., Elston C.W., Grainge M.J., Hodi Z., et al. Prognostic significance of Nottingham histologic grade in invasive breast carcinoma. Journal of Clinical Oncology 2008, 26:3153-3158.
23. Sánchez-Tilló E., Siles L., De Barrios O., Cuatrecasas M., Vaquero E.C., Castells A., et al. Expanding roles of ZEB factors in tumorigenesis and tumor progression. American Journal of Cancer Research 2012, 2:897-912.
24. Sayan A.E., Griffiths T.R., Pal R., Browne G.J., Ruddick A., Yagci T., et al. SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:14884-14889.
25. Schulte J., Weidig M., Balzer P., Richter P., Franz M., Junker K., et al. Expression of the E-cadherin repressors Snail, Slug and Zeb1 in urothelial carcinoma of the urinary bladder: relation to stromal fibroblast activation and invasive behaviour of carcinoma cells. Histochemistry and Cell Biology 2012, 138:847-860.
26. Soini Y., Tuhkanen H., Sironen R., Virtanen I., Kataja V., Auvinen P., et al. Transcription factors zeb1, twist and snai1 in breast carcinoma. BMC Cancer 2011, 11:73.
27. Spoelstra N.S., Manning N.G., Higashi Y., Darling D., Singh M., Shroyer K.R., et al. The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers. Cancer Research 2006, 66:3893-3902.
28. Vail D.M., MacEwen E.G. Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Investigation 2000, 18:781-792.
29. Vandewalle C., Van Roy F., Berx G. The role of the ZEB family of transcription factors in development and disease. Cellular and Molecular Life Sciences 2009, 66:773-787.
30. Walsh M.M., Bleiweiss I.R.A.J. Invasive micropapillary carcinoma of the breast: eighty cases of an under-recognized entity. Human Pathology 2001, 32:583-589.
31. Yoshida J., Horiuchi A., Kikuchi N., Hayashi A., Osada R., Ohira S., et al. Changes in the expression of E-cadherin repressors, Snail, Slug, SIP1, and Twist, in the development and progression of ovarian carcinoma: the important role of Snail in ovarian tumorigenesis and progression. Medical Molecular Morphology 2009, 42:82-91.